Canamedics is in the process of obtaining the relevant licenses to produce EU GMP cannabis dried flowers to be used as active pharmaceutical ingredients (APIs). Canamedics' EU GACP/GMP production facilities will be located in Barcelona, Spain. Canamedics will be fully operational by 2021. As its starting plant materials, Canamedics prides on its catalogue of legal certified origin cannabis strains obtained from verified suppliers. The client will choose the strain and Canamedics will grow and deliver EU GMP cannabis dried flowers to be used as APIs. In addition to that, Canamedics is sponsoring pre-clinical trials committed to research into the efficacy and safety of the use of cannabinoids in the treatment of pain and muscle stiffness derived from neurological diseases.